22nd Century Return on Tangible Equity 2011-2023 | XXII
Current and historical return on tangible equity values for 22nd Century (XXII) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| 22nd Century Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.15B |
$-0.01B |
-1463.41% |
| 2023-09-30 |
$-0.14B |
$0.01B |
-383.33% |
| 2023-06-30 |
$-0.08B |
$0.02B |
-151.46% |
| 2023-03-31 |
$-0.07B |
$0.03B |
-115.74% |
| 2022-12-31 |
$-0.06B |
$0.09B |
-92.55% |
| 2022-09-30 |
$-0.05B |
$0.07B |
-83.93% |
| 2022-06-30 |
$-0.04B |
$0.05B |
-76.11% |
| 2022-03-31 |
$-0.04B |
$0.05B |
-55.81% |
| 2021-12-31 |
$-0.03B |
$0.06B |
-50.79% |
| 2021-09-30 |
$-0.02B |
$0.07B |
-41.74% |
| 2021-06-30 |
$-0.02B |
$0.08B |
-37.81% |
| 2021-03-31 |
$-0.02B |
$0.04B |
-47.62% |
| 2020-12-31 |
$-0.02B |
$0.04B |
-43.68% |
| 2020-09-30 |
$-0.02B |
$0.04B |
-39.58% |
| 2020-06-30 |
$-0.03B |
$0.05B |
-50.76% |
| 2020-03-31 |
$-0.03B |
$0.05B |
-54.90% |
| 2019-12-31 |
$-0.03B |
$0.05B |
-48.60% |
| 2019-09-30 |
$-0.03B |
$0.05B |
-52.25% |
| 2019-06-30 |
$-0.01B |
$0.05B |
-21.14% |
| 2019-03-31 |
$-0.01B |
$0.06B |
-18.68% |
| 2018-12-31 |
$-0.01B |
$0.06B |
-13.48% |
| 2018-09-30 |
$-0.00B |
$0.07B |
-5.86% |
| 2018-06-30 |
$-0.01B |
$0.06B |
-23.32% |
| 2018-03-31 |
$-0.01B |
$0.07B |
-20.45% |
| 2017-12-31 |
$-0.01B |
$0.07B |
-43.33% |
| 2017-09-30 |
$-0.01B |
$0.02B |
-69.57% |
| 2017-06-30 |
$-0.01B |
$0.02B |
-84.21% |
| 2017-03-31 |
$-0.01B |
$0.01B |
-102.13% |
| 2016-12-31 |
$-0.01B |
$0.02B |
-114.29% |
| 2016-09-30 |
$-0.01B |
$0.01B |
-165.52% |
| 2016-06-30 |
$-0.01B |
$0.01B |
-177.78% |
| 2016-03-31 |
$-0.01B |
$0.01B |
-137.93% |
| 2015-12-31 |
$-0.01B |
$0.00B |
-176.00% |
| 2015-09-30 |
$-0.01B |
$0.01B |
-193.10% |
| 2015-06-30 |
$-0.01B |
$0.01B |
-155.56% |
| 2015-03-31 |
$-0.02B |
$0.01B |
-176.47% |
| 2014-12-31 |
$-0.02B |
$0.01B |
-168.42% |
| 2014-09-30 |
$-0.02B |
$0.01B |
-200.00% |
| 2014-06-30 |
$-0.03B |
$0.01B |
-3000.00% |
| 2014-03-31 |
$-0.03B |
$0.01B |
933.33% |
| 2013-12-31 |
$-0.03B |
$0.01B |
346.67% |
| 2013-09-30 |
$-0.02B |
$-0.02B |
204.65% |
| 2013-06-30 |
$-0.01B |
$-0.01B |
96.55% |
| 2013-03-31 |
$-0.01B |
$-0.01B |
121.74% |
| 2012-12-31 |
$-0.01B |
$-0.01B |
133.33% |
| 2012-09-30 |
$-0.00B |
$-0.00B |
28.57% |
| 2012-06-30 |
$-0.00B |
$-0.00B |
26.67% |
| 2012-03-31 |
$-0.00B |
$-0.00B |
53.33% |
| 2011-12-31 |
$-0.00B |
$-0.00B |
30.77% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.006B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
